KRAS and cancer: The questions of how SIAH selectively interacts with its binding partners and degrades these substrates in response to oncogenic K-RAS activation, and how SIAH and newly identified SIAH substrates promote and facilitate oncogenic K-RAS-driven tumorigenesis and metastasis, remain to be elucidated in cancer biology.